<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34689061</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-3064</ISSN><JournalIssue CitedMedium="Internet"><Volume>189</Volume><PubDate><Year>2021</Year><Season>Nov-Dec</Season></PubDate></JournalIssue><Title>Respiratory medicine</Title><ISOAbbreviation>Respir Med</ISOAbbreviation></Journal><ArticleTitle>Respiratory rehabilitation for Covid-19 related persistent dyspnoea: A one-year experience.</ArticleTitle><Pagination><StartPage>106648</StartPage><MedlinePgn>106648</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rmed.2021.106648</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0954-6111(21)00356-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">Growing consideration is emerging regarding the burden of persisting sequelae after SARS-CoV-2 infection. Out-patients exhibiting long Covid may benefit from ambulatory rehabilitation which is, to date, poorly documented.</AbstractText><AbstractText Label="METHODS">A longitudinal follow-up over a one-year period was conducted in two ambulatory rehabilitation structures in order to describe the characteristics of real-life patients referred with Covid-19 sequelae and their evolution over the course of rehabilitation.</AbstractText><AbstractText Label="RESULTS">39 consecutive patients were included from April 1st<sup>,</sup> 2020 to April 1st<sup>,</sup> 2021. Patients were middle-aged (48&#xa0;&#xb1;&#xa0;15yr), without comorbidities, and mostly mild to moderate SARS-CoV-2 infection (25(64%) not requiring hospitalisation). Rehabilitation referral was considered with a median delay of 73[34-178] days after disease onset. Most prevalent symptoms were dyspnoea (n&#xa0;=&#xa0;35(90%)) and fatigue (n&#xa0;=&#xa0;30(77%)). Hyperventilation syndrome was highly frequent (n&#xa0;=&#xa0;12(34%)). 29(74%) patients presented with prolonged functional sequelae, which was associated with younger age (43&#xa0;&#xb1;&#xa0;14 vs. 50&#xa0;&#xb1;&#xa0;10yr; p&#xa0;=&#xa0;0.002), greater prevalence of hyperventilation syndrome (n&#xa0;=&#xa0;12(41%) vs. 0(0%); p&#xa0;=&#xa0;0.255) and poorer quality of life (VQ-11; 31&#xa0;&#xb1;&#xa0;10 vs. 23&#xa0;&#xb1;&#xa0;9; p&#xa0;=&#xa0;0.030). Over the course of rehabilitation, exertional dyspnoea, 6-min walking distance, 3-min sit-to-stand test, hyperventilation syndrome prevalence and quality of life significantly improved.</AbstractText><AbstractText Label="CONCLUSION">Hyperventilation is frequent in long Covid and may explain persistent dyspnoea as well as altered quality of life. Our data support screening of hyperventilation syndrome and functional impairment in mild Covid-19 out-patients as both of these components may improve with ambulatory rehabilitation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bouteleux</LastName><ForeName>Benoit</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Cabinet Resp'Air, 33400, Talence, France. Electronic address: benoit.bouteleux@respair.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henrot</LastName><ForeName>Pauline</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Bordeaux, Centre de Recherche Cardio-Thoracique de Bordeaux, INSERM U1045, 33604, Pessac, France; CHU de Bordeaux, D&#xe9;partement de Physiologie, Service des Explorations Fonctionnelles Respiratoires, 33604, Pessac, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ernst</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cabinet Resp'Air, 33400, Talence, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grassion</LastName><ForeName>L&#xe9;o</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>CHU de Bordeaux, H&#xf4;pital du Haut-L&#xe9;v&#xea;que, D&#xe9;partement de Pneumologie, 33604, Pessac, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raherison-Semjen</LastName><ForeName>Chantal</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>CHU de Bordeaux, H&#xf4;pital du Haut-L&#xe9;v&#xea;que, D&#xe9;partement de Pneumologie, 33604, Pessac, France; Universit&#xe9; de Bordeaux, Epicene, INSERM U1219, 33076, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beaufils</LastName><ForeName>Fabien</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Bordeaux, Centre de Recherche Cardio-Thoracique de Bordeaux, INSERM U1045, 33604, Pessac, France; CHU de Bordeaux, D&#xe9;partement de Physiologie, Service des Explorations Fonctionnelles Respiratoires, 33604, Pessac, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zysman</LastName><ForeName>Ma&#xe9;va</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Bordeaux, Centre de Recherche Cardio-Thoracique de Bordeaux, INSERM U1045, 33604, Pessac, France; CHU de Bordeaux, H&#xf4;pital du Haut-L&#xe9;v&#xea;que, D&#xe9;partement de Pneumologie, 33604, Pessac, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delorme</LastName><ForeName>Mathieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cabinet Resp'Air, 33400, Talence, France; Universit&#xe9; Paris-Saclay, UVSQ, ERPHAN, 78000, Versailles, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Respir Med</MedlineTA><NlmUniqueID>8908438</NlmUniqueID><ISSNLinking>0954-6111</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000534" MajorTopicYN="Y">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006985" MajorTopicYN="N">Hyperventilation</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000534" MajorTopicYN="Y">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010045" MajorTopicYN="N">Outpatients</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012017" MajorTopicYN="N">Referral and Consultation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012046" MajorTopicYN="N">Rehabilitation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012119" MajorTopicYN="Y">Respiration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ambulatory physiotherapy</Keyword><Keyword MajorTopicYN="N">Hyperventilation syndrome</Keyword><Keyword MajorTopicYN="N">Long Covid</Keyword><Keyword MajorTopicYN="N">Post-Covid-19 syndrome</Keyword><Keyword MajorTopicYN="N">Respiratory rehabilitation</Keyword></KeywordList><CoiStatement>MZ reports grants and personal fees from Boehringer Ingelheim, personal fees from Novartis, personal fees from Chiesi, personal fees from Astra Zeneca and personal fees from GSK outside the submitted work. FB reports personal fees and non-financial support from Novartis, personal fees and non-financial support from Chiesi, grants, personal fees and non-financial support from AstraZeneca, outside the submitted work.PH reports non-financial support from Avad, outside the submitted work. Other authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>24</Day><Hour>20</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34689061</ArticleId><ArticleId IdType="pmc">PMC8511554</ArticleId><ArticleId IdType="doi">10.1016/j.rmed.2021.106648</ArticleId><ArticleId IdType="pii">S0954-6111(21)00356-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., Zhao Y., Li Y., Wang X., Peng Z. Clinical characteristics of 138 Hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan, China. J. Am. Med. Assoc. 2020;323:1061&#x2013;1069. doi: 10.1001/jama.2020.1585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. J. Am. Med. Assoc. 2020;323:1239&#x2013;1242. doi: 10.1001/jama.2020.2648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas P., Baldwin C., Bissett B., Boden I., Gosselink R., Granger C.L., Hodgson C., Jones A.Y., Kho M.E., Moses R., Ntoumenopoulos G., Parry S.M., Patman S., van der Lee L. Physiotherapy management for COVID-19 in the acute hospital setting: clinical practice recommendations. J. Physiother. 2020;66:73&#x2013;82. doi: 10.1016/j.jphys.2020.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jphys.2020.03.011</ArticleId><ArticleId IdType="pmc">PMC7165238</ArticleId><ArticleId IdType="pubmed">32312646</ArticleId></ArticleIdList></Reference><Reference><Citation>Spruit M.A., Holland A.E., Singh S.J., Tonia T., Wilson K.C., Troosters T. COVID-19: interim guidance on rehabilitation in the hospital and post-hospital phase from a European respiratory society and American thoracic society-coordinated international task force. Eur. Respir. J. 2020 doi: 10.1183/13993003.02197-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02197-2020</ArticleId><ArticleId IdType="pmc">PMC7427118</ArticleId><ArticleId IdType="pubmed">32817258</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalmers J.D., Crichton M.L., Goeminne P.C., Cao B., Humbert M., Shteinberg M., Antoniou K.M., Ulrik C.S., Parks H., Wang C., Vandendriessche T., Qu J., Stolz D., Brightling C., Welte T., Aliberti S., Simonds A.K., Tonia T., Roche N. Management of hospitalised adults with coronavirus disease-19 (COVID-19): a European Respiratory Society living guideline. Eur. Respir. J. 2021 doi: 10.1183/13993003.00048-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00048-2021</ArticleId><ArticleId IdType="pmc">PMC7947358</ArticleId><ArticleId IdType="pubmed">33692120</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerum T.V., Aal&#xf8;kken T.M., Br&#xf8;nstad E., Aarli B., Ikdahl E., Lund K.M.A., Durheim M.T., Rodriguez J.R., Meltzer C., Tonby K., Stavem K., Skj&#xf8;nsberg O.H., Ashraf H., Einvik G. Dyspnoea, lung function and CT findings 3monthsafter hospital admission for COVID -19. Eur. Respir. J. 2021;57:2003448. doi: 10.1183/13993003.03448-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03448-2020</ArticleId><ArticleId IdType="pmc">PMC7736755</ArticleId><ArticleId IdType="pubmed">33303540</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., Liu X., Zhou Y., Yu H., Li R., Zhan Q., Ni F., Fang S., Lu Y., Ding X., Liu H., Ewing R.M., Jones M.G., Hu Y., Nie H., Wang Y. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir. Med. 2021;9:747&#x2013;754. doi: 10.1016/S2213-2600(21)00174-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00174-0</ArticleId><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Froidure A., Mahsouli A., Liistro G., De Greef J., Belkhir L., G&#xe9;rard L., Bertrand A., Koenig S., Pothen L., Yildiz H., Mwenge B., Aboubakar F., Gohy S., Pilette C., Reychler G., Coche E., Yombi J.-C., Ghaye B. Integrative respiratory follow-up of severe COVID-19 reveals common functional and lung imaging sequelae. Respir. Med. 2021;181:106383. doi: 10.1016/j.rmed.2021.106383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106383</ArticleId><ArticleId IdType="pmc">PMC8019490</ArticleId><ArticleId IdType="pubmed">33839588</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajwah S., Wilcock A., Towers R., Costantini M., Bausewein C., Simon S.T., Bendstrup E., Prentice W., Johnson M.J., Currow D.C., Kreuter M., Wells A.U., Birring S.S., Edmonds P., Higginson I.J. Managing the supportive care needs of those affected by COVID-19. Eur. Respir. J. 2020;55 doi: 10.1183/13993003.00815-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00815-2020</ArticleId><ArticleId IdType="pmc">PMC7144268</ArticleId><ArticleId IdType="pubmed">32269090</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir. Med. 2021;9:129. doi: 10.1016/S2213-2600(21)00031-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Committee for the COMEBAC Study Group. Morin L., Savale L., Pham T., Colle R., Figueiredo S., Harrois A., Gasnier M., Lecoq A.-L., Meyrignac O., Noel N., Baudry E., Bellin M.-F., Beurnier A., Choucha W., Corruble E., Dortet L., Hardy-Leger I., Radiguer F., Sportouch S., Verny C., Wyplosz B., Zaidan M., Becquemont L., Montani D., Monnet X. Four-Month clinical status of a cohort of patients after hospitalization for COVID-19. J. Am. Med. Assoc. 2021 doi: 10.1001/jama.2021.3331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.3331</ArticleId><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Cort&#xe9;s-Telles A., L&#xf3;pez-Romero S., Figueroa-Hurtado E., Pou-Aguilar Y.N., Wong A.W., Milne K.M., Ryerson C.J., Guenette J.A. Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea. Respir. Physiol. Neurobiol. 2021;288:103644. doi: 10.1016/j.resp.2021.103644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resp.2021.103644</ArticleId><ArticleId IdType="pmc">PMC7910142</ArticleId><ArticleId IdType="pubmed">33647535</ArticleId></ArticleIdList></Reference><Reference><Citation>Trinkmann F., M&#xfc;ller M., Reif A., Kahn N., Kreuter M., Trudzinski F., Eichinger M., Heussel C.-P., Herth F.J.F. Lung Network Rhine-Neckar-Region, Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection. Eur. Respir. J. 2021;57 doi: 10.1183/13993003.03002-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03002-2020</ArticleId><ArticleId IdType="pmc">PMC7821834</ArticleId><ArticleId IdType="pubmed">33479105</ArticleId></ArticleIdList></Reference><Reference><Citation>Motiejunaite J., Balagny P., Arnoult F., Mangin L., Bancal C., d'Ortho M.-P., Frija-Masson J., Hyperventilation A possible explanation for long-lasting exercise intolerance in mild COVID-19 survivors? Front. Physiol. 2020;11:614590. doi: 10.3389/fphys.2020.614590.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.614590</ArticleId><ArticleId IdType="pmc">PMC7849606</ArticleId><ArticleId IdType="pubmed">33536937</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrejak C., Cottin V., Crestani B., Debieuvre D., Gonzalez-Bermejo J., Morelot-Panzini C., Stach B., Uzunhan Y., Maitre B., Raherison C. [Guide for management of patients with possible respiratory sequelae after a SARS-CoV-2 pneumonia. Rev. Mal. Respir. 2020 doi: 10.1016/j.rmr.2020.11.009. Support proposals developed by the French-speaking Respiratory Medicine Society. Version of 10 November 2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmr.2020.11.009</ArticleId><ArticleId IdType="pmc">PMC7691188</ArticleId><ArticleId IdType="pubmed">33280941</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise J. Long covid: WHO calls on countries to offer patients more rehabilitation. BMJ. 2021;372:n405. doi: 10.1136/bmj.n405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n405</ArticleId><ArticleId IdType="pubmed">33568362</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe9;drinal C., Combret Y., Bonnevie T., Smondack P., Gravier F.E., Lebret M., Prieur G. Physiotherapy during the Covid-19 pandemic: management of critically ill patients in the ICU and follow-up care. Eur. Rehabil. J. 2021:1&#x2013;8. doi: 10.52057/erj.v1i1.2. 01.</Citation><ArticleIdList><ArticleId IdType="doi">10.52057/erj.v1i1.2</ArticleId></ArticleIdList></Reference><Reference><Citation>Knudson R.J., Slatin R.C., Lebowitz M.D., Burrows B. The Maximal Expiratory Flow-Volume Curve. Normal standards, variability, and effects of age. Am. Rev. Respir. Dis. 1976;113:587&#x2013;600. doi: 10.1164/arrd.1976.113.5.587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/arrd.1976.113.5.587</ArticleId><ArticleId IdType="pubmed">1267262</ArticleId></ArticleIdList></Reference><Reference><Citation>Enright P.L., Sherrill D.L. Reference equations for the six-minute walk in healthy adults. Am. J. Respir. Crit. Care Med. 1998;158:1384&#x2013;1387. doi: 10.1164/ajrccm.158.5.9710086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.158.5.9710086</ArticleId><ArticleId IdType="pubmed">9817683</ArticleId></ArticleIdList></Reference><Reference><Citation>Coquart J.B., Heutte N., Terce G., Grosbois J.-M. Convergent validity and minimal clinically important difference of the maugeri foundation respiratory failure questionnaire (MRF-28) and the chronic obstructive pulmonary disease-specific health-related quality of life questionnaire (VQ11) Int. J. Chron. Obstruct. Pulmon. Dis. 2019;14:2895&#x2013;2903. doi: 10.2147/COPD.S222165.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/COPD.S222165</ArticleId><ArticleId IdType="pmc">PMC6916677</ArticleId><ArticleId IdType="pubmed">31853177</ArticleId></ArticleIdList></Reference><Reference><Citation>Ninot G., Soyez F., Pr&#xe9;faut C. A short questionnaire for the assessment of quality of life in patients with chronic obstructive pulmonary disease: psychometric properties of VQ11. Health Qual. Life Outcome. 2013;11:179. doi: 10.1186/1477-7525-11-179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7525-11-179</ArticleId><ArticleId IdType="pmc">PMC3842624</ArticleId><ArticleId IdType="pubmed">24160852</ArticleId></ArticleIdList></Reference><Reference><Citation>Beekman E., Verhagen A. Clinimetrics: hospital anxiety and depression scale. J. Physiother. 2018;64:198. doi: 10.1016/j.jphys.2018.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jphys.2018.04.003</ArticleId><ArticleId IdType="pubmed">29895416</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dixhoorn J., Duivenvoorden H.J. Efficacy of Nijmegen Questionnaire in recognition of the hyperventilation syndrome. J. Psychosom. Res. 1985;29:199&#x2013;206. doi: 10.1016/0022-3999(85)90042-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3999(85)90042-x</ArticleId><ArticleId IdType="pubmed">4009520</ArticleId></ArticleIdList></Reference><Reference><Citation>Vansteenkiste J., Rochette F., Demedts M. Diagnostic tests of hyperventilation syndrome. Eur. Respir. J. 1991;4:393&#x2013;399.</Citation><ArticleIdList><ArticleId IdType="pubmed">1855568</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M., Taylor S. NICE guideline on long covid. BMJ. 2020;371:m4938. doi: 10.1136/bmj.m4938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4938</ArticleId><ArticleId IdType="pubmed">33361141</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T., Sahanic S., Pizzini A., Luger A., Schwabl C., Sonnweber B., Kurz K., Koppelst&#xe4;tter S., Haschka D., Petzer V., Boehm A., Aichner M., Tymoszuk P., Lener D., Theurl M., Lorsbach-K&#xf6;hler A., Tancevski A., Schapfl A., Schaber M., Hilbe R., Nairz M., Puchner B., H&#xfc;ttenberger D., Tschurtschenthaler C., A&#xdf;hoff M., Peer A., Hartig F., Bellmann R., Joannidis M., Gollmann-Tepek&#xf6;yl&#xfc; C., Holfeld J., Feuchtner G., Egger A., Hoermann G., Schroll A., Fritsche G., Wildner S., Bellmann-Weiler R., Kirchmair R., Helbok R., Prosch H., Rieder D., Trajanoski Z., Kronenberg F., W&#xf6;ll E., Weiss G., Widmann G., L&#xf6;ffler-Ragg J., Tancevski I. Cardiopulmonary recovery after COVID-19 - an observational prospective multi-center trial. Eur. Respir. J. 2020 doi: 10.1183/13993003.03481-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03481-2020</ArticleId><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Taverne J., Salvator H., Leboulch C., Barizien N., Ballester M., Imhaus E., Chabi-Charvillat M.-L., Boulin A., Goyard C., Chabrol A., Catherinot E., Givel C., Couderc L.-J., Tcherakian C. High incidence of hyperventilation syndrome after COVID-19. J. Thorac. Dis. 2021;13:3918&#x2013;3922. doi: 10.21037/jtd-20-2753.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd-20-2753</ArticleId><ArticleId IdType="pmc">PMC8264705</ArticleId><ArticleId IdType="pubmed">34277081</ArticleId></ArticleIdList></Reference><Reference><Citation>Motiejunaite J., Balagny P., Arnoult F., Mangin L., Bancal C., Vidal-Petiot E., Flamant M., Jondeau G., Cohen-Solal A., d'Ortho M.-P., Frija-Masson J. Hyperventilation as one of the mechanisms of persistent dyspnoea in SARS-CoV-2 survivors. Eur. Respir. J. 2021;58:2101578. doi: 10.1183/13993003.01578-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01578-2021</ArticleId><ArticleId IdType="pmc">PMC8361302</ArticleId><ArticleId IdType="pubmed">34385265</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E. Characterizing long COVID in an international Cohort: 7 months of symptoms and their impact | medRxiv. https://www.medrxiv.org/content/10.1101/2020.12.24.20248802v1.full n.d. (accessed April 5, 2021)</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.24.20248802v1.full</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs L.G., Gourna Paleoudis E., Lesky-Di Bari D., Nyirenda T., Friedman T., Gupta A., Rasouli L., Zetkulic M., Balani B., Ogedegbe C., Bawa H., Berrol L., Qureshi N., Aschner J.L. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS One. 2020;15 doi: 10.1371/journal.pone.0243882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0243882</ArticleId><ArticleId IdType="pmc">PMC7732078</ArticleId><ArticleId IdType="pubmed">33306721</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. MedRxiv Prepr. Serv. Health Sci. 2021 doi: 10.1101/2021.01.27.21250617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.27.21250617</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S., Barnett J., Brill S.E., Brown J.S., Denneny E.K., Hare S.S., Heightman M., Hillman T.E., Jacob J., Jarvis H.C., Lipman M.C.I., Naidu S.B., Nair A., Porter J.C., Tomlinson G.S., Hurst J.R. Thorax; 2020. ARC Study Group, &#x201c;Long-COVID&#x201d;: a Cross-Sectional Study of Persisting Symptoms, Biomarker and Imaging Abnormalities Following Hospitalisation for COVID-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz Y.M.J., Van Herck M., Delbressine J.M., Vaes A.W., Meys R., Machado F.V.C., Houben-Wilke S., Burtin C., Posthuma R., Franssen F.M.E., van Loon N., Hajian B., Spies Y., Vijlbrief H., van &#x2019;t Hul A.J., Janssen D.J.A., Spruit M.A. Persistent symptoms 3monthsafter a SARS -CoV-2infection :the post -COVID-19syndrome. ERJ Open Res. 2020;6 doi: 10.1183/23120541.00542-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohr A., Dannerbeck L., Lange T.J., Pfeifer M., Blaas S., Salzberger B., Hitzenbichler F., Koch M. Cardiopulmonary exercise pattern in patients with persistent dyspnoea after recovery from COVID-19, Multidiscip. Respir. Med. 2021;16:732. doi: 10.4081/mrm.2021.732.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/mrm.2021.732</ArticleId><ArticleId IdType="pmc">PMC7893311</ArticleId><ArticleId IdType="pubmed">33623700</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed M., Withana K., Stephenson J.B. Hyperventilation syndrome. Lancet Lond. Engl. 1996;348:65634&#x2013;65636. doi: 10.1016/s0140-6736(05. 750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(05</ArticleId><ArticleId IdType="pubmed">8806302</ArticleId></ArticleIdList></Reference><Reference><Citation>Brat K., Stastna N., Merta Z., Olson L.J., Johnson B.D., Cundrle I. Cardiopulmonary exercise testing for identification of patients with hyperventilation syndrome. PLoS One. 2019;14 doi: 10.1371/journal.pone.0215997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0215997</ArticleId><ArticleId IdType="pmc">PMC6478351</ArticleId><ArticleId IdType="pubmed">31013331</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornsveld H.K., Garssen B., Dop M.J., van Spiegel P.I., de Haes J.C. Double-blind placebo-controlled study of the hyperventilation provocation test and the validity of the hyperventilation syndrome. Lancet Lond. Engl. 1996;348:154&#x2013;158. doi: 10.1016/s0140-6736(96)02024-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(96)02024-7</ArticleId><ArticleId IdType="pubmed">8684155</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulding R., Stacey R., Niven R., Fowler S.J. Dysfunctional breathing: a review of the literature and proposal for classification. Eur. Respir. Rev. Off. J. Eur. Respir. Soc. 2016;25:287&#x2013;294. doi: 10.1183/16000617.0088-2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0088-2015</ArticleId><ArticleId IdType="pmc">PMC9487208</ArticleId><ArticleId IdType="pubmed">27581828</ArticleId></ArticleIdList></Reference><Reference><Citation>Ristiniemi H., Perski A., Lyskov E., Emtner M. Hyperventilation and exhaustion syndrome. Scand. J. Caring Sci. 2014;28:657&#x2013;664. doi: 10.1111/scs.12090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/scs.12090</ArticleId><ArticleId IdType="pmc">PMC4282474</ArticleId><ArticleId IdType="pubmed">24134551</ArticleId></ArticleIdList></Reference><Reference><Citation>Zampogna E., Paneroni M., Belli S., Aliani M., Gandolfo A., Visca D., Bellanti M.T., Ambrosino N., Vitacca M. Pulmonary rehabilitation in patients recovering from COVID-19, respir. Int. Rev. Thorac. Dis. 2021;100:416&#x2013;422. doi: 10.1159/000514387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000514387</ArticleId><ArticleId IdType="pmc">PMC8089404</ArticleId><ArticleId IdType="pubmed">33784696</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemh&#xf6;fer C., Gutenbrunner C., Schiller J., Loudovici-Krug D., Best N., B&#xf6;kel A., Sturm C. Assessment of rehabilitation needs in patients after COVID-19: development of the COVID-19-rehabilitation needs survey. J. Rehabil. Med. 2021;53 doi: 10.2340/16501977-2818. jrm00183.</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/16501977-2818</ArticleId><ArticleId IdType="pmc">PMC8814869</ArticleId><ArticleId IdType="pubmed">33764478</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>